TrialThe lancet. Diabetes & endocrinology2020

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial.

Daisuke Yabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.